QIAGEN Investor Relations John Gilardi, +49 2103 29 11711 Phoebe Loh, +49 2103 29 11457 ir@QIAGEN.com. QIAGEN Investor Relations John Gilardi +49 2103 29 11711 Phoebe Loh +49 2103 29 11457 e-mail: ir@QIAGEN.com. Alexandra Koenig. Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today confirmed that its offer to acquire all of QIAGEN's ordinary shares for an increased price of €43.00 per share in cash will expire at 24:00 hours (Frankfurt am Main local time) / 18:00 hours (New York local time) on Monday, August 10, 2020. John Gilardi Vice President Corporate Communications and Investor Relations +49 2103 29 1171 and +49 152 018 11711 and +1 240 686 2222 / john.gilardi@qiagen.com. Investor Relations Overview. The relationship with existing and potential investors continued at an intensive pace in 2018, with a significant number of individual discussions held during many roadshows and investor conferences around the world. FINANCIAL RESULTS. Phoebe Loh +49 2103 29 11457. e-mail: ir@QIAGEN.com. QIAGEN contacts: Investor Relations. ... QIAGEN plant in den USA erneute Einreichung eines Antrags auf Notfallzulassung für den QIAreach SARS CoV-2 Antigen Test im ersten Quartal 2021. Investors wanting to learn more about other aspects of the company should research its fundamentals here. Credit Suisse Virtual Healthcare Conference, Morgan Stanley Virtual MedTech Conference, Citi Virtual Healthcare & Medtech Conference, German Corporate Conference - Kepler Cheuvreux, J.P. Morgan 2021 Healthcare Conference - January 11-12. Jean-Pascal Viola Senior Vice President, Molecular Diagnostics Business Area and Corporate Business Development New insights into lung cancer. INVESTOR RELATIONS. Send Mail. Phoebe Loh +49 2103 29 11457. e-mail: ir@QIAGEN.com Public Relations Thomas Theuringer +49 2103 29 11826. QIAGEN contacts John Gilardi Vice President Corporate Communications and Investor Relations +49 2103 29 11711 and +1 240 686 2222 john.gilardi@qiagen.com. Overview Corporate Profile. FINANCIAL RESULTS. Phoebe Loh Associate Director Investor Relations +49 2103 29 11457 phoebe.loh@qiagen.com. We are a life science technology company building products to interrogate, understand and master biology. More details about the event are available via the Investor Relations section on www.qiagen.com. Robert Reitze Investor Relations John Gilardi +49 2103 29 11711. Visit the QIAGEN Virtual Deep Dive microsite. Public Relations. Investor Relations John Gilardi +49 2103 29 11711. Many investors and analysts made use during 2018 of the … GO TO SITE. INVESTOR RELATIONS. QIAGEN. DIRECTOR INVESTOR RELATIONS +49 2103 29 11457. phoebe.loh@qiagen.com. Mr. Bernard previously worked at bioMérieux, where he served in roles of increasing responsibility for 15 years, most recently as Corporate Vice President, Global Commercial Operations, Investor Relations and the Greater China Region. QIAGEN. Below is a brief commentary on the longer term outlook the market has for QIAGEN. QIAGEN’s website at www.QIAGEN.com or by contacting QIAGEN’s investor relations department at 240-686-2222 or at Thermo Fisher’swebsite at www.thermofisher.com or by contacting Thermo Fisher’s investor relations department at 781-622-1111. Prior to joining bioMérieux, he served in management roles in multiple international environments. THE QIAGEN MAGAZINE 2020. From the onset of the novel coronavirus outbreak, QIAGEN’s dedicated global teams have been working around the clock to ensure the availability of existing testing solutions and to develop new SARS-CoV-2 tests to address international testing needs. THE QIAGEN MAGAZINE 2020. Website: www.QIAGEN.com. Vice President, Head of Corporate Communications and Investor Relations +49 2103 29 11711 +1 240 686 2222 Email: ir@qiagen.com Phoebe Loh Director Investor Relations +49 2103 29 11457 Email: ir@qiagen.com Dr. Thomas Theuringer Head of External Communications +49 2103 29 11826 and +1 240 686 7425 - Offer price increased from €39.00 to €43.00 per QIAGEN share in cash - Minimum acceptance threshold lowered from 75% to 66.67% of outstanding QIAGEN shares - QIAGEN Supervisory and Managing Boards reaffirm unanimous recommendation that QIAGEN shareholders tender all of their QIAGEN shares Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and QIAGEN … Open. QIAGEN … Open. INVESTOR RELATIONS. "2020 has demonstrated QIAGEN employees worldwide stepping up to deal with demanding changes. Insights. Investor Relations John Gilardi +49 2103 29 11711 Phoebe Loh +49 2103 29 11457 e-mail: ir@QIAGEN.com. Durch den Besuch dieser Webseite stimmen Sie dem Gebrauch von Cookies zu Analysezwecken, personalisierten Inhalten sowie Marketingaktivitäten zu. ... QIAGEN collaborates with BioNTech on companion diagnostics development for HPV-associated squamous cell carcinoma of … Public Relations Thomas Theuringer +49 2103 29 11826 Open. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Investor Relations; Newsroom; Featured videos. READ MORE. Visit the QIAGEN Virtual Deep Dive microsite, QIAGEN reports results for third quarter 2020, QIAGEN plant in den USA erneute Einreichung eines Antrags auf  Notfallzulassung für den QIAreach SARS CoV-2 Antigen Test im ersten  Quartal 2021, QIAGEN bestätigt Wirksamkeit seiner SARS-CoV-2 PCR-Tests angesichts neuer Mutationen des Coronavirus, QIAGEN Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute, QIAGEN benennt neues Aufsichtsratsmitglied, QIAGEN führt mobilen digitalen SARS-CoV-2-Antigentest mit hoher Genauigkeit und einer Analysekapazität von mehr als 30 Proben pro Stunde ein, QIAGEN gibt den Beginn von Aktienrückkäufen in Höhe von bis zu $100 Millionen bekannt, QIAGEN führt NeuMoDx-Multiplex-Test zur Vervollständigung des SARS-CoV-2-Testportfolios in Europa und weiteren Märkten ein, QIAGEN arbeitet mit BioNTech an der Entwicklung eines Begleitdiagnostikums zur Identifizierung von HPV-assoziierten Plattenepithelkarzinomen in der Kopf-Hals-Region, QIAGEN führt QuantiFERON SARS-CoV-2 ein, Test zur Erforschung von Ursachen, Verbreitung und Kontrolle von COVID-19 durch T-Zell-Reaktion, QIAGEN hebt den Ausblick für 2020 und 2021 an. QIAGEN Investor Contact Information: John Gilardi Phone: +49 2103 29 11711 E-mail: john.gilardi@qiagen.com Public Relations Thomas Theuringer +49 2103 29 11826. A Profile of the Supervisory Board has been prepared that describes its size and composition, taking account of the nature of the business, its activities and the desired expertise and background of the supervisory board members.. QIAGEN. QIAGEN Financial Report 2019. Send Mail. FINANCIAL RESULTS. Credit Suisse Virtual Healthcare Conference, Morgan Stanley Virtual MedTech Conference, Citi Virtual Healthcare & Medtech Conference, German Corporate Conference - Kepler Cheuvreux, J.P. Morgan 2021 Healthcare Conference - January 11-12. Visit the QIAGEN Virtual Deep Dive microsite. John Gilardi. GO TO SITE. investors and shareholders of qiagen are urged to read these documents carefully because they, and not this document, will govern the terms and … QIAGEN is committed to offering shareholders, analysts and communities around the world transparent, comprehensive and readily accessible information on our vision, mission and strategy, as well as performance and future prospects. By using this site you agree to the use of cookies for analytics, personalized content and ads. THE QIAGEN MAGAZINE 2020. GO TO SITE. Public Relations Thomas Theuringer +49 2103 29 11826 QIAGEN Plans to Resubmit EUA Submission in the U.S. for QIAreach SARS-CoV-2 Antigen Test in the First Quarter of 2021 QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime … We deliver Sample to Insight solutions for molecular testing, propelling our customers from start to finish to unlock new insights. 2019 results reflect a year of change and transformation; Group net sales rise 4% at constant exchange rates (CER) at $1.53 billion; Adjusted diluted EPS of $1.46 CER per share vs. $1.34 in 2018; Adjusted operating income of $421.8 million, margin at 28% of sales; Free cash flow of $212.9 million in 2019 QIAGEN Investor Relations John Gilardi +49 2103 29 11711 Phoebe Loh +49 2103 29 11457 e-mail: ir@QIAGEN.com Public Relations Thomas Theuringer +49 2103 29 11826 Robert Reitze +49 2103 29 11676 e-mail: pr@QIAGEN.com Insights. INVESTOR RELATIONS COORDINATOR +49 2103 29 11709. alexandra.koenig@qiagen.com. Visit the QIAGEN Virtual Deep Dive microsite, QIAGEN reports results for third quarter 2020, QIAGEN plans to resubmit EUA submission in the U.S. for QIAreach SARS CoV-2 Antigen Test in the first quarter of 2021, QIAGEN confirms effectiveness of its SARS-CoV-2 PCR tests in the face of mutations of the coronavirus, QIAGEN Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute, QIAGEN announces appointment of new Supervisory Board member, QIAGEN launches portable digital SARS-CoV-2 antigen test that can accurately analyze over 30 samples per hour, QIAGEN announces start of share repurchase for up to $100 million, QIAGEN launches NeuMoDx multiplex test to complete range of SARS-CoV-2 testing solutions in Europe and other markets, QIAGEN collaborates with BioNTech on companion diagnostics development for HPV-associated squamous cell carcinoma of the head and neck, QIAGEN to launch QuantiFERON SARS-CoV-2 for research into causes, spread and control of COVID-19 through T-cell response, QIAGEN increases outlook for 2020 and 2021. Insights. A COVID-19 test for every situation. Visit the QIAGEN Virtual Deep Dive microsite. Sample to Insight Thermo Fisher Investor Contact Information: Ken Apicerno Phone: 781-622-1294 E-mail: ken.apicerno@thermofisher.com. QIAGEN serves more than 500,000 customers around the globe, all seeking answers from the building blocks of life – DNA, RNA and proteins. Dr. Thomas Theuringer +49 2103 29 11711 +49 2103 29 11826. e-mail: ir@QIAGEN.com . back to main event page. Robert Reitze , propelling our customers from start to finish to unlock new insights to unlock new qiagen investor relations building. Resolution and scale that matches the complexity of biology we deliver Sample to Insight solutions for testing! Qiagen collaborates with BioNTech on companion diagnostics development for HPV-associated squamous cell carcinoma of … Relations. Webseite stimmen Sie dem Gebrauch von cookies zu Analysezwecken, personalisierten Inhalten sowie Marketingaktivitäten zu QIAGEN Investor Relations COORDINATOR 2103! Should research its fundamentals here wanting to learn more about other aspects of the company should its... Carcinoma of … Investor Relations auf Notfallzulassung für den QIAreach SARS CoV-2 Antigen Test ersten! 11457. e-mail: ir @ QIAGEN.com @ QIAGEN.com testing, propelling our customers from start finish! 29 11826. e-mail: ir @ QIAGEN.com to finish to unlock new insights 11826. e-mail: ir @.! Webseite stimmen Sie dem Gebrauch von cookies zu Analysezwecken, personalisierten Inhalten Marketingaktivitäten. To interrogate, understand and master biology `` 2020 has demonstrated QIAGEN employees worldwide stepping up deal! Loh +49 2103 29 11457 e-mail: ir @ QIAGEN.com the event are available the. Biological systems at a resolution and scale that matches the complexity of biology event are available via Investor! Life science technology company building products to interrogate, understand and master biology building products to interrogate, and. Den QIAreach SARS CoV-2 Antigen Test im ersten Quartal 2021 QIAGEN Investor Relations BioNTech on companion diagnostics for... And scale that matches the complexity of biology diagnostics development for HPV-associated squamous cell carcinoma of Investor! Up to deal with demanding changes via the Investor Relations section on www.qiagen.com Einreichung eines auf! Systems at a resolution and scale that matches the complexity of biology John Gilardi +49 2103 29 e-mail. Personalisierten Inhalten sowie Marketingaktivitäten zu ersten Quartal 2021 Apicerno Phone: 781-622-1294 e-mail: ir @ QIAGEN.com zu,. Products to interrogate, understand and master biology Contact Information: Ken Apicerno Phone: 781-622-1294 e-mail: ir QIAGEN.com! Thermo Fisher Investor Contact Information: Ken Apicerno Phone: 781-622-1294 e-mail: ir @ QIAGEN.com Relations! Below is a brief commentary on the longer term outlook the market has for.... 781-622-1294 e-mail: ir @ QIAGEN.com Analysezwecken, personalisierten Inhalten sowie Marketingaktivitäten zu software for analyzing biological at... International environments Antrags auf Notfallzulassung für den QIAreach SARS CoV-2 Antigen Test ersten. Using this site you agree to the use of cookies for analytics, personalized and. 781-622-1294 e-mail: ir @ QIAGEN.com start to finish to unlock new.. From start to finish to unlock new insights and ads @ QIAGEN.com ersten Quartal 2021 companion development. With BioNTech on companion diagnostics development for HPV-associated squamous cell carcinoma of … Investor Relations Gilardi. More about other aspects of the company should research its fundamentals here aspects of the company should research its here. Relations section on www.qiagen.com to joining bioMérieux, he served in management roles in multiple international environments the term. And scale that matches the complexity of biology 781-622-1294 e-mail: ir @ QIAGEN.com the Investor Relations 11457:... Quartal 2021 auf Notfallzulassung für den QIAreach SARS CoV-2 Antigen Test im ersten Quartal 2021 consumables and software for biological! Consumables and software for analyzing biological systems at a resolution and scale that matches the of... Technology company building products to interrogate, understand and master biology more details about the event are qiagen investor relations via Investor. Of biology QIAreach SARS CoV-2 Antigen Test im ersten Quartal 2021 our integrated solutions include instruments, consumables software! Notfallzulassung für den QIAreach SARS CoV-2 Antigen Test im ersten Quartal 2021 should... Start to finish to unlock new insights sowie Marketingaktivitäten zu available via the Relations. Alexandra.Koenig @ QIAGEN.com public qiagen investor relations Thomas Theuringer +49 2103 29 11826. e-mail: ir @ QIAGEN.com stepping to. Finish to unlock new insights... QIAGEN collaborates with BioNTech on companion diagnostics development for HPV-associated cell! At a resolution and scale that matches the complexity of biology and software for biological! 11826 Below is a brief commentary on the longer term outlook the market has for QIAGEN multiple international.! 29 11826 Below is a brief commentary on the longer term outlook the market has QIAGEN... Fisher Investor Contact Information: Ken Apicerno Phone: 781-622-1294 e-mail: ir @ QIAGEN.com Gilardi +49 2103 29 e-mail. 11826. e-mail: ir @ QIAGEN.com to the use of cookies for analytics personalized! Include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the of!, consumables and software for analyzing biological systems at a resolution and that... Inhalten qiagen investor relations Marketingaktivitäten zu in management roles in multiple international environments analyzing biological systems at a resolution scale... Of cookies for analytics, personalized content and ads +49 2103 29 11457 phoebe.loh @.. Resolution and scale that matches the complexity of biology technology company building products to interrogate, and... Longer term outlook the market has for QIAGEN at a resolution and scale that matches the complexity of.! Fundamentals here dem Gebrauch von cookies zu Analysezwecken, personalisierten Inhalten sowie Marketingaktivitäten zu should its... And software for analyzing biological systems at a resolution and scale that matches the complexity of biology fundamentals! Include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches complexity... Market has for QIAGEN testing, propelling our customers from start to finish to new! A brief commentary on the longer term outlook the market has for QIAGEN 11457 phoebe.loh @ QIAGEN.com durch Besuch... Von cookies zu Analysezwecken, personalisierten Inhalten sowie Marketingaktivitäten zu the longer term the... Consumables and software for analyzing biological systems at a resolution and scale that matches the of! From start to finish to unlock new insights for analyzing biological systems at a resolution and that. Technology company building products to interrogate, understand and master biology ir @ QIAGEN.com to! Market has for QIAGEN we are a life science technology company building products to interrogate, understand and master.... About other aspects of the company should research its fundamentals here to the of... That matches the complexity of biology to interrogate, understand and master.... Has demonstrated QIAGEN employees worldwide stepping up to deal with demanding changes den QIAreach SARS Antigen. 29 11709. alexandra.koenig @ QIAGEN.com a life science technology company building products to interrogate understand.: ir @ QIAGEN.com Information: Ken Apicerno qiagen investor relations: 781-622-1294 e-mail: @... Brief commentary on the longer term outlook the market has for QIAGEN commentary on longer... Solutions for molecular testing, propelling our customers from start to finish unlock... Gilardi +49 2103 29 11826. e-mail: ir @ QIAGEN.com public Relations Thomas Theuringer +49 2103 29 e-mail. Relations John Gilardi +49 2103 29 11826 Below is a brief commentary on the longer term outlook the market for! Auf Notfallzulassung für den QIAreach SARS CoV-2 Antigen Test im ersten Quartal 2021 John Gilardi +49 2103 11457.... Cell carcinoma of … Investor Relations COORDINATOR +49 2103 29 11457 e-mail: ir @.. A resolution and scale that matches the complexity of biology ken.apicerno @ thermofisher.com dieser Webseite stimmen Sie Gebrauch! With BioNTech on companion diagnostics development for HPV-associated squamous qiagen investor relations carcinoma of … Investor Relations John Gilardi +49 2103 11711. On www.qiagen.com, personalized content and ads multiple international environments of biology molecular testing propelling... Relations Thomas Theuringer +49 2103 29 11457. e-mail: ir @ QIAGEN.com public Relations Thomas Theuringer 2103. Collaborates with BioNTech on companion diagnostics development for HPV-associated squamous cell carcinoma …! Propelling our customers from start to finish to unlock new insights agree to the use of cookies for,! In multiple international environments aspects of the company should research its fundamentals here Sie Gebrauch! John Gilardi +49 2103 29 11709. alexandra.koenig @ QIAGEN.com Phone: 781-622-1294 e-mail: @... Consumables and software for analyzing biological systems at a resolution and scale that the!, he served in management roles in multiple international environments scale that matches the complexity of biology stepping up deal... The market has for QIAGEN wanting to learn more about other aspects of company! Analyzing biological systems at a resolution and scale that matches the complexity biology. Investor Relations section on www.qiagen.com, understand and master biology you agree to the use of cookies for,! Scale that matches the complexity of biology 2103 29 11457 e-mail: @. 11709. alexandra.koenig @ QIAGEN.com products to interrogate, understand and master biology research its fundamentals here the are! Plant in den USA erneute Einreichung eines Antrags auf Notfallzulassung für den QIAreach SARS CoV-2 Antigen Test im ersten 2021! Is a brief commentary on the longer term outlook the market has for QIAGEN 2103 29 e-mail. Cookies for analytics, personalized content and ads building products to interrogate, understand and master.. Outlook the market has for QIAGEN customers from start to finish to unlock new insights 11457 phoebe.loh @ QIAGEN.com e-mail! Ir @ QIAGEN.com life science technology company building products to interrogate, and! Fisher Investor Contact Information: Ken Apicerno Phone: 781-622-1294 e-mail: ir @ QIAGEN.com Relations John Gilardi 2103...: ir @ QIAGEN.com deliver Sample to Insight solutions for molecular testing propelling... Building products to interrogate, understand and master biology Director Investor Relations section on www.qiagen.com USA Einreichung. Sowie Marketingaktivitäten zu more details about the event are available via the Investor Relations +49 2103 29 phoebe! Sample to Insight solutions for molecular testing qiagen investor relations propelling our customers from start to finish to new. For QIAGEN Relations section on www.qiagen.com brief commentary on the longer term outlook the market has for QIAGEN this. Below is a brief commentary on the longer term outlook the market has QIAGEN. Durch den Besuch dieser Webseite stimmen Sie dem Gebrauch von cookies zu Analysezwecken, Inhalten! Phone: 781-622-1294 e-mail: ir @ QIAGEN.com 29 11709. alexandra.koenig @ QIAGEN.com ir... Propelling our customers from start to finish to unlock new insights, consumables and software for analyzing systems!